Advisory Services Network’s Bicycle Therapeutics BCYC Stock Holding History

Advisory Services Network’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-115	Closed	-$2.08K	–	1671
2023 Q4	$2.08K	Buy	+115	New	+$1.9K	﹤0.01%	3393
2023 Q2	–	Sell	-115	Closed	-$2.45K	–	1657
2023 Q1	$2.45K	Hold	115	–	–	﹤0.01%	3376
2022 Q4	$3.4K	Buy	+115	New	+$3.08K	﹤0.01%	3260
2021 Q3	–	Sell	-100	Closed	-$3K	–	1566
2021 Q2	$3K	Buy	+100	New	+$3.02K	﹤0.01%	3194
2021 Q1	–	Sell	-100	Closed	-$2K	–	1439
2020 Q4	$2K	Hold	100	–	–	﹤0.01%	2974
2020 Q3	$2K	Buy	+100	New	+$1.77K	﹤0.01%	3067

Other funds holding BCYC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Advisory Services Network's BCYC Position: Q1 2024 in Review

Advisory Services Network sold out of Bicycle Therapeutics (BCYC) in Q1 2024, closing a stake of 115 shares — an estimated $2.08K sold.

Advisory Services Network first reported a position in BCYC in Q3 2020 and held it in 6 quarters. The position peaked at $3.4K in Q4 2022. 95 funds tracked by Wall St. Rank hold BCYC as of Q1 2024.

Advisory Services Network reported no remaining Bicycle Therapeutics position as of Q1 2024 after selling out during the quarter.
Advisory Services Network sold 115 Bicycle Therapeutics shares in Q1 2024, an estimated $2.08K.
Advisory Services Network first reported a position in Bicycle Therapeutics in Q3 2020 and held it in 6 quarters.
Advisory Services Network's Bicycle Therapeutics position peaked at $3.4K in Q4 2022.
95 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.